Abbott Laboratories (Brazil) Performance
| ABTT34 Stock | BRL 61.14 1.38 2.31% |
Abbott Laboratories has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.36, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Abbott Laboratories are expected to decrease at a much lower rate. During the bear market, Abbott Laboratories is likely to outperform the market. Abbott Laboratories right now shows a risk of 2.12%. Please confirm Abbott Laboratories mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and total risk alpha , to decide if Abbott Laboratories will be following its price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Abbott Laboratories is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 9.8 B |
Abbott |
Abbott Laboratories Relative Risk vs. Return Landscape
If you would invest 5,896 in Abbott Laboratories on December 25, 2024 and sell it today you would earn a total of 218.00 from holding Abbott Laboratories or generate 3.7% return on investment over 90 days. Abbott Laboratories is generating 0.0838% of daily returns and assumes 2.1161% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than Abbott, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Abbott Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abbott Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abbott Laboratories, and traders can use it to determine the average amount a Abbott Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0396
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ABTT34 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.12 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Abbott Laboratories is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abbott Laboratories by adding it to a well-diversified portfolio.
Abbott Laboratories Fundamentals Growth
Abbott Stock prices reflect investors' perceptions of the future prospects and financial health of Abbott Laboratories, and Abbott Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abbott Stock performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0882 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 1.07 T | |||
| Shares Outstanding | 20.92 B | |||
| Price To Earning | 40.47 X | |||
| Price To Book | 5.41 X | |||
| Price To Sales | 22.38 X | |||
| Revenue | 43.65 B | |||
| EBITDA | 10.69 B | |||
| Cash And Equivalents | 8.37 B | |||
| Cash Per Share | 1.18 X | |||
| Total Debt | 17.3 B | |||
| Debt To Equity | 0.55 % | |||
| Book Value Per Share | 5.12 X | |||
| Cash Flow From Operations | 10.53 B | |||
| Earnings Per Share | 1.69 X | |||
| Total Asset | 75.2 B | |||
About Abbott Laboratories Performance
By analyzing Abbott Laboratories' fundamental ratios, stakeholders can gain valuable insights into Abbott Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Abbott Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Abbott Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is based in North Chicago, Illinois. ABBOTT DRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 109000 people.Things to note about Abbott Laboratories performance evaluation
Checking the ongoing alerts about Abbott Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abbott Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating Abbott Laboratories' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Abbott Laboratories' stock performance include:- Analyzing Abbott Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abbott Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Abbott Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abbott Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abbott Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abbott Laboratories' stock. These opinions can provide insight into Abbott Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Abbott Stock analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |